Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Take Solutions Ltd

Healthcare | Small Cap

Take Solutions Ltd Health Insights
Health Score : 3.89Health Score : 3.89

Take Solutions Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strengths in solvency and growth, particularly in earnings per share. However, it struggles with liquidity, efficiency, coverage, financial metrics, and profitability. While the company's earnings per share growth and equity-related solvency metrics are positive, its poor liquidity and profitability raise concerns. The company's ability to meet its short-term obligations and generate profits is questionable. The healthcare industry's dynamics, including regulatory changes and competitive pressures, could further affect the company's financial stability. The company needs to address these weaknesses to ensure long-term sustainability and growth.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Take Solutions Ltd Health Insights
Health Score : 3.89Health Score : 3.89

Take Solutions Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strengths in solvency and growth, particularly in earnings per share. However, it struggles with liquidity, efficiency, coverage, financial metrics, and profitability. While the company's earnings per share growth and equity-related solvency metrics are positive, its poor liquidity and profitability raise concerns. The company's ability to meet its short-term obligations and generate profits is questionable. The healthcare industry's dynamics, including regulatory changes and competitive pressures, could further affect the company's financial stability. The company needs to address these weaknesses to ensure long-term sustainability and growth.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

166.83

Neutral

Industry Median

34.78

Neutral
Overvalued

Small Cap Median

28.42

Overvalued

P/E RATIO

41.14

P/B RATIO

14.30

Overvalued

Industry Median

11.62

Overvalued
Highly Overvalued

Small Cap Median

8.93

Highly Overvalued

P/S RATIO

8.23

Overvalued

Industry Median

6.05

Overvalued
Highly Overvalued

Small Cap Median

3.87

Highly Overvalued

Others

Neutral

PEG RATIO

0.00

Neutral
Overvalued

EV/EBITDA RATIO

40.38

Overvalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹30.03 as on Jun 19, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 4.00

The company exhibits mixed growth performance. While earnings per share (EPS) growth is strong, revenue, operating profit, asset, and net income growth rates are low. This suggests that while the company is improving its profitability on a per-share basis, it is not experiencing overall growth in key areas such as revenue and assets. The healthcare sector's growth is influenced by factors such as demographics, healthcare spending, and technological advancements. The company needs to focus on driving revenue and asset growth to ensure long-term sustainability.

PoorRevenue Growth RatePoor
PoorOperating Profit Growth RatePoor
ExcellentEarnings Per Share (EPS) GrowthExcellent
PoorAsset Growth RatePoor
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate-15.37-71.15-97.88-100
Operating Profit Growth Rate-109.59-371.435.26-65-71.43
Earnings Per Share (EPS) Growth73.04-87.1819.32-131.27-71.15
Asset Growth Rate-33.02-81.68-60.71-59.090
Net Income Growth Rate73.78-87.2120-130.83-70.27
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 2.80

The company's financial metrics show a mixed performance. Cash earnings per share is low, and book value per share is also at a minimal level. This could be due to poor profitability, asset write-downs, or excessive dividend payments. These factors can erode shareholder value. The healthcare sector's financial performance is influenced by factors such as reimbursement rates, patient volumes, and regulatory changes. The company needs to focus on improving its profitability and managing its assets effectively to enhance its financial metrics.

PoorAdjusted Earnings Per Share (Adjusted EPS)Poor
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
WeakCapital Expenditures (CapEx)Weak
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)-52.13-6-5.332.470.27
Cash Earnings Per Share (Cash EPS)-46.8-5.53-7.932.470.73
Book Value Per Share12.077.27-0.61.42.07
Dividend Per Share (DPS)00000
Capital Expenditures (CapEx)31.231.97.800
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 2.00

The company's profitability ratios are generally weak across all metrics. Low gross profit, return on capital employed (ROCE), return on equity (ROE), return on assets (ROA), operating margin, and net margin indicate significant challenges in generating profits from its operations. This could be due to high operating expenses, competitive pressures, or inefficient operations. The healthcare sector's profitability is influenced by factors such as reimbursement rates, patient volumes, and regulatory changes. The company needs to address these factors to improve its overall profitability.

PoorGross Profit MarginPoor
PoorReturn on Capital Employed (ROCE)Poor
PoorReturn on Equity (ROE)Poor
PoorReturn on Assets (ROA)Poor
PoorOperating MarginPoor
PoorNet MarginPoor
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin-11.15-19.05-525-3.7
Return on Capital Employed (ROCE)-6-14-2219
Return on Equity (ROE)-432.04-91.7435.48
Return on Assets (ROA)0.57-8.48-22.73-5.56
Operating Margin1.07-10.05-500-3.7
Net Margin-119.39-52.91-300020.37
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 4.67

The company's efficiency ratios present a mixed picture. While days sales in inventory and receivable days suggest efficient management of inventory and collections, the fixed asset, inventory, receivables, and capital turnover ratios are low, indicating underutilization of assets and potential inefficiencies in operations. This could be due to underinvestment in technology or poor management of resources. The healthcare sector's operational complexities, including patient scheduling and resource allocation, could affect these ratios. The company should focus on improving asset utilization to enhance overall efficiency.

PoorFixed Asset Turnover RatioPoor
PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
ExcellentDays Sales in Inventory RatioExcellent
ExcellentReceivable DaysExcellent
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio6.492.590.13
Inventory Turnover Ratio1155.56314.6931.6517.5N/A
Receivables Turnover Ratio2.543.390.220490.91
Days Sales in Inventory Ratio0.321.1611.5320.86N/A
Receivable Days143.7107.671659.090.74
Capital Turnover Ratio3.131.484.5501.74
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 2.00

The company's coverage ratios are weak, particularly the interest coverage ratio. The interest coverage ratio being low indicates difficulties in meeting interest obligations. This raises concerns about the company's ability to service its debt. The healthcare sector's capital-intensive nature and regulatory requirements can affect coverage ratios. The company should focus on improving its earnings and managing its debt effectively to enhance its coverage ratios.

PoorInterest Coverage RatioPoor
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio-25.86-13.14-5719.5N/A
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 10.00

The company's solvency position is strong, primarily driven by high equity ratio. The debt and debt to asset ratio being zero suggests that the company is not using debt to finance its assets. This can reduce financial risk. With a solid equity base, the company appears financially stable and less vulnerable to economic downturns. The healthcare sector's inherent stability, due to consistent demand for services, can further support the company's solvency, but this also reflects a missed opportunity to leverage debt for growth.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
ExcellentEquity RatioExcellent
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.140.1511.2300
Debt to Equity Ratio0.160.18-1.100
Equity Ratio0.860.85-10.2311
Debt To Asset Ratio0.020.080.1100
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.00

The company's liquidity position appears weak across all measured metrics. The current, quick, and cash ratios are all at minimal levels, suggesting a limited ability to meet short-term obligations with available assets. The operating cash flow ratio also indicates challenges in generating sufficient cash from operations to cover current liabilities. This situation could restrict the company's financial flexibility and increase its dependence on external financing. However, the healthcare industry's specific working capital cycles should be considered when evaluating these ratios.

PoorCurrent RatioPoor
PoorQuick RatioPoor
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio1.11.450.672.257.2
Quick Ratio1.11.440.662.257.2
Cash Ratio0.030.120.010.210.06
Operating Cash Flow Ratio0.030.210.1-1-0.8
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 2 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Yash Optics & Lens Ltd6.1529.97Neutral14.743.659.05
2Take Solutions Ltd3.8941.14Neutral-2.000.1811.00
Management Assessment Summary
RedWeak Management

The management of Take Solutions Ltd. faces significant challenges, reflected in declining financial performance and operational inefficiencies. The company's inability to sustain sales growth and profitability raises concerns about strategic decision-making. While promoter holding remains consistent, the decrease in institutional interest suggests a lack of confidence in management's ability to improve the company's prospects. These factors contribute to a negative outlook on the management's effectiveness.

Category Metric Value Assessment
CONS Sales Growth Declining Sales from 2019 to 2025 Sales have decreased significantly, indicating potential issues with market positioning or product offerings.
Operating Profit Margin Negative OPM in recent years The operating profit margin is also negative, which indicates ineffecient operations.
Institutional Interest Decreased FII and DII holdings Decreased institutional interest indicates a lack of confidence in the company's future performance.
PoorFinancial Performance & GrowthPoor
PoorCapital Efficiency & ReturnsPoor
WeakFinancial Health & PrudenceWeak
AverageShareholding & Ownership StructureAverage
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
RedWeak Risk

Take Solutions faces high risk due to negative profitability, declining sales, and inconsistent cash flows. Operational inefficiencies, reflected in negative ROCE, and decreasing institutional interest increase the risk profile. The company's weak financial performance and market indicators warrant careful monitoring and strategic adjustments to mitigate these risks.

WeakAccounting quality red flagsWeak
AverageForeign exchange or interest rate exposureAverage
01.

Accounting quality red flags

02.

Foreign exchange or interest rate exposure

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1029.73Bullish
  3. SMA 2029.68Bullish
  4. SMA 5029.75Bullish
  5. EMA 1029.79Bullish
  6. EMA 2029.74Bullish
  7. EMA 5029.75Bullish
  8. DEMA 1029.90Bullish
  9. DEMA 2029.77Bullish
  10. DEMA 5029.70Bullish
  11. TEMA 1030.01Bullish
  12. TEMA 2029.83Bullish
  13. TEMA 5029.72Bullish
  14. MACD0.04Bullish
  15. ADX48.78Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI62.99Neutral
  3. CCI232.40Overbought
  4. ROC 92.74Bullish
  5. ROC 141.77Bullish
  6. ROC 252.15Bullish
  7. Stoch K78.68Neutral
  8. Stoch D66.47Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper30.16Overbought
  3. BB Middle29.68Neutral
  4. BB Lower29.21Neutral
  5. ATR0.58High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI25.35Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1029.75Bullish
  3. SMA 2029.76Bullish
  4. SMA 5029.77Bullish
  5. EMA 1029.82Bullish
  6. EMA 2029.78Bullish
  7. EMA 5029.86Bullish
  8. DEMA 1029.91Bullish
  9. DEMA 2029.79Bullish
  10. DEMA 5029.48Bullish
  11. TEMA 1030.01Bullish
  12. TEMA 2029.85Bullish
  13. TEMA 5030.10Bullish
  14. MACD0.02Bullish
  15. ADX31.20Strong Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI59.85Neutral
  3. CCI232.86Overbought
  4. ROC 92.70Bullish
  5. ROC 142.56Bullish
  6. ROC 253.08Bullish
  7. Stoch K75.05Neutral
  8. Stoch D68.89Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper30.23Overbought
  3. BB Middle29.76Neutral
  4. BB Lower29.28Neutral
  5. ATR0.77High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI38.59Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1029.77Bullish
  3. SMA 2029.75Bullish
  4. SMA 5029.22Bullish
  5. EMA 1029.80Bullish
  6. EMA 2029.81Bullish
  7. EMA 5030.75Bearish
  8. DEMA 1029.84Bullish
  9. DEMA 2029.71Bullish
  10. DEMA 5027.88Bullish
  11. TEMA 1029.90Bullish
  12. TEMA 2029.97Bullish
  13. TEMA 50N/AN/A
  14. MACD-0.08Bullish
  15. ADX18.85Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI55.23Neutral
  3. CCI181.06Overbought
  4. ROC 92.49Bullish
  5. ROC 141.84Bullish
  6. ROC 25-0.10Bearish
  7. Stoch K64.74Neutral
  8. Stoch D59.75Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper30.23Overbought
  3. BB Middle29.75Neutral
  4. BB Lower29.28Neutral
  5. ATR1.07High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI25.08Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1029.60Bullish
  3. SMA 2029.82Bearish
  4. SMA 5035.67Bearish
  5. SMA 10038.64Bearish
  6. SMA 20031.92Bearish
  7. EMA 1029.69Bullish
  8. EMA 2030.26Bearish
  9. EMA 5033.41Bearish
  10. EMA 10034.83Bearish
  11. EMA 20031.74Bearish
  12. DEMA 1029.56Bullish
  13. DEMA 2028.43Bullish
  14. DEMA 5029.49Bullish
  15. DEMA 10035.81Bearish
  16. DEMA 20038.80Bearish
  17. TEMA 1029.83Bearish
  18. TEMA 2029.42Bullish
  19. TEMA 5026.53Bullish
  20. TEMA 10030.93Bearish
  21. TEMA 20040.32Bearish
  22. MACD-1.17Bullish
  23. ADX28.64Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI39.42Neutral
  3. CCI-39.00Neutral
  4. ROC 14-3.38Bearish
  5. ROC 254.97Bullish
  6. Stoch K41.49Neutral
  7. Stoch D40.14Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper31.11Neutral
  3. BB Middle29.82Neutral
  4. BB Lower28.53Neutral
  5. ATR1.53High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI19.07Oversold

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2038.94Bearish
  3. SMA 5028.52Bullish
  4. EMA 2035.23Bearish
  5. EMA 5030.62Bearish
  6. DEMA 2035.88Bearish
  7. DEMA 5038.15Bearish
  8. TEMA 2031.29Bearish
  9. TEMA 5041.54Bearish
  10. MACD-0.30Bearish
  11. ADX33.60Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI47.96Neutral
  3. CCI6.03Neutral
  4. ROC 14-13.75Bearish
  5. ROC 25-16.04Bearish
  6. Stoch K25.43Neutral
  7. Stoch D22.40Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper53.13Neutral
  3. BB Middle38.94Neutral
  4. BB Lower24.76Neutral
  5. ATR4.45Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI69.73Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bearish

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 639.47Bearish
  3. SMA 1227.49Bullish
  4. SMA 2421.11Bullish
  5. EMA 635.36Bearish
  6. EMA 1230.45Bullish
  7. EMA 2425.96Bullish
  8. DEMA 639.16Bearish
  9. DEMA 1238.04Bearish
  10. DEMA 2428.63Bullish
  11. TEMA 637.12Bearish
  12. TEMA 1241.85Bearish
  13. TEMA 2437.94Bearish
  14. MACD-6.35Bullish
  15. ADX25.89Strong Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI48.08Neutral
  3. CCI106.80Overbought
  4. ROC 2535.09Bullish
  5. ROC 506.21Bullish
  6. Stoch K49.53Neutral
  7. Stoch D25.56Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper47.79Neutral
  3. BB Middle21.29Neutral
  4. BB Lower-5.20Neutral
  5. ATR7.72High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI91.60Overbought